No. S 721
Health Products Act
(Chapter 122D)
Health Products (Cosmetic Products — ASEAN Cosmetic Directive) (Amendment) Regulations 2010
In exercise of the powers conferred by sections 71(1) and 72 of the Health Products Act, the Health Sciences Authority, with the approval of the Minister for Health, hereby makes the following Regulations:
Citation and commencement
1.  These Regulations may be cited as the Health Products (Cosmetic Products — ASEAN Cosmetic Directive) (Amendment) Regulations 2010 and shall come into operation on 1st January 2011.
Deletion and substitution of First Schedule
2.  The First Schedule to the Health Products (Cosmetic Products — ASEAN Cosmetic Directive) Regulations 2007 (G.N. No. S 683/2007) is deleted and the following Schedule substituted therefor:
FIRST SCHEDULE
Regulation 4(2)
Fees for Submission of Notification
1.  In relation to —
(a) any product intended for application around the eyes or on the lips;
 
 
(b) any oral or dental care product; or
 
 
(c) any hair dye containing diamine compounds,
 
 
for —
 
 
(i) a new notification or further notification under regulation 4(1)(b) for a single product or each of the first 3 variants of a product; or
 
$25
(ii) a new notification or further notification under regulation 4(1)(b) for each of the fourth and subsequent variants of a product
 
$5.
 
 
 
 
2.  In relation to any product not referred to in item 1 —
 
 
(a) for a new notification or further notification under regulation 4(1)(b) for a single product or each of the first 3 variants of a product; or
 
$10
(b) for a new notification or further notification under regulation 4(1)(b) for each of the fourth and subsequent variants of a product
 
$5.
 
 
 
 
3.  In this Schedule —
“base formulation” means a partial cosmetic formulation shared by 2 or more cosmetic preparations manufactured by the same manufacturer and intended for the same use;
“variant” means a cosmetic preparation that is largely similar in composition to another cosmetic preparation (usually having a common base formulation) but having a different colour, shade, flavour, fragrance or other inherent characteristic apart from the base formulation.
Made this 26th day of November 2010.
EDISON LIU
Chairman,
Health Sciences Authority,
Singapore.
[HAS (HPRG) 401:04/01-000; AG/LLRD/SL/122D/2010/2 Vol. 1]
(To be presented to Parliament under section 72(5) of the Health Products Act).